ページ本文へ移動
pepts.wiki

私たちは医師ではなく、ここにある内容は医療上の助言ではありません。必ず先に医療専門家に相談してください。 この表示をする理由

英語からの機械翻訳です。英語版が基準です。 英語で読む

栄養素または補酵素Stub

L-Ornithine

尿素回路のアミノ酸

尿素回路のアミノ酸です。サプライヤーが単体およびブレンド製品として販売しているため、このライブラリに掲載されていますが、研究用ペプチドではありません。

概要

栄養素または補酵素

ビタミン、アミノ酸、または補酵素です。単独および配合製品として販売されているため掲載しています。

このページは作成途中です

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

L-Ornithine: PubMedで

What PubMed held for L-Ornithine on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

505
papers
150
in humans
28
clinical trials
24
randomized trials
2012: 6 papers122013: 12 papers2014: 19 papers142015: 20 papers2016: 11 papers162017: 10 papers2018: 21 papers182019: 17 papers2020: 10 papers202021: 8 papers2022: 23 papers222023: 10 papers2024: 10 papers242025: 16 papers2026: 18 papers so far26
Papers per year, 2012 to 2026. The most in one year: 23.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial

    Randomized trialJain A, Sharma BC, Mahajan B, et al. Hepatology (Baltimore, Md.), 2022. PMID 34822189

  2. Intravenous versus oral 'L-ornithine-L-aspartate' in overt hepatic encephalopathy: a randomized comparative study

    Randomized trialJhajharia A, Singh S, Jana S, et al. Scientific reports, 2024. PMID 38789596

  3. Safety assessment of L-ornithine oral intake in healthy subjects: a systematic review

    ReviewYang H, Kuramochi Y, Sato S, et al. Amino acids, 2025. PMID 40323503

  4. L-ornithine L-aspartate in bouts of overt hepatic encephalopathy

    Randomized trialSidhu SS, Sharma BC, Goyal O, et al. Hepatology (Baltimore, Md.), 2018. PMID 28749571

  5. L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis

    Meta-analysisJiang Q, Jiang XH, Zheng MH, et al. Journal of gastroenterology and hepatology, 2009. PMID 18823442

  6. Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis

    Meta-analysisButterworth RF Metabolic brain disease, 2020. PMID 31338724

  7. Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's disease

    StudyWang Z, Tian L, Jiang Y, et al. Cell metabolism, 2025. PMID 39978335

  8. L-Ornithine L-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic

    StudyButterworth RF Drugs, 2019. PMID 30706421

Search used: ("L-Ornithine"[ti]). Run it on PubMed

研究リンク

Also in Vitamins and cofactors

Sold in blends: Super Human Blend